The comparison of APOE 4ε carriers, especially APOE 4ε heterozygotes in MS, with healthy subjects might not be efficient enough to exclude the influence of other APOE ε alleles, for no evidence as yet has confirmed a similar or contrary effect among apoE isoforms on susceptibility to or clinical severity of MS. The gene discussed is APOE; the disease is myeloid sarcoma.